PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.45%
Revenue growth under 50% of WEED.TO's 10.92%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
2.54%
Gross profit growth under 50% of WEED.TO's 71.07%. Michael Burry would be concerned about a severe competitive disadvantage.
-215.47%
Negative EBIT growth while WEED.TO is at 84.69%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-15.44%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-117.73%
Negative net income growth while WEED.TO stands at 81.19%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-120.58%
Negative EPS growth while WEED.TO is at 84.62%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-123.71%
Negative diluted EPS growth while WEED.TO is at 84.62%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-1.20%
Share reduction while WEED.TO is at 21.85%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.20%
Reduced diluted shares while WEED.TO is at 21.85%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-15.34%
Negative OCF growth while WEED.TO is at 68.82%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
3.14%
FCF growth under 50% of WEED.TO's 67.42%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
No Data
No Data available this quarter, please select a different quarter.
-43.07%
Negative 5Y CAGR while WEED.TO stands at 25.46%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-27.65%
Negative 3Y CAGR while WEED.TO stands at 43.99%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-3018.29%
Negative 10Y OCF/share CAGR while WEED.TO stands at 15.32%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
67.43%
5Y OCF/share CAGR at 75-90% of WEED.TO's 83.25%. Bill Ackman would push for operational improvements to match competitor’s mid-term gains.
-26.57%
Negative 3Y OCF/share CAGR while WEED.TO stands at 84.45%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-5286.33%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-248.74%
Negative 5Y net income/share CAGR while WEED.TO is 26.50%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-882.73%
Negative 3Y CAGR while WEED.TO is 95.79%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
10337.78%
10Y equity/share CAGR above 1.5x WEED.TO's 207.79%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
-34.81%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-58.34%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.36%
Our AR growth while WEED.TO is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
0.65%
We show growth while WEED.TO is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-1.65%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
0.34%
Positive BV/share change while WEED.TO is negative. John Neff sees a clear edge over a competitor losing equity.
-3.77%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-42.86%
Our R&D shrinks while WEED.TO invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-7.77%
We cut SG&A while WEED.TO invests at 245.39%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.